Egis World
Egis' products are sold to 100 countries.

Agreement for Biosimilar Candidates in Key Central and Eastern European Markets
• mAbxience and Egis collaborate on the commercialization of two biosimilar candidates • The agreement covers eight Central and Eastern European countries with the potential for expansion into additional territories • mAbxience will serve as the marketing authorization holder, while Egis will manage commercialization in the designated regions More

Csaba Poroszlai at the conference on the competitiveness of the European and Hungarian pharmaceutical industry

Under the patronage of Márton Nagy, Minister of National Economy, the Hungarian Pharmaceutical Manufacturers Association (MAGYOSZ) held its annual conference, focusing on enhancing the competitiveness of the domestic and European pharmaceutical industry. In his speech, the minister emphasized that the pharmaceutical industry is a historical sector in Hungary and a crucial pillar of growth. More

Ten Years Together – Egis Pharmaceuticals PLC Remains the Partner of the Körmend Basketball Team

The red-black team of the Vas county town and one of the largest Hungarian pharmaceutical companies have extended their cooperation for another year. The team will continue to play under the name Egis Körmend in the championship. More

This was the year we commemorated the 110th anniversary of the foundation of our company

Continuous modernisations and investment, launch of a new line of business, tree planting, exhibitions, and a short story contest. In 2023 Egis commemorated its 110th anniversary with a special series of events.

More

Professional award for our joint project with the Örkény Theatre

The Art is Business Award recognizes outstanding collaborations between representatives of the corporate sector and the arts scene.

More

The Night of Modern Factories – another busy evening in our visitor centre

Plenty of visitors registered for the event in the Egis Science and Technology Centre.

More

The winners of the one minute story contest receive their awards

Egis Pharmaceuticals PLC and Örkény Theatre have launched several joint initiatives celebrating the 110th anniversary of the company’s foundation.

More
Other channels
Our People
Our mission is to serve people with all of our skills, ensuring that they live a long and healthy life
Health
In the 2022/2023 business year, the company’s product portfolio consisted of 653 products
Innovation
In the 2022/2023 business year, we spent EUR 48 million on research and development
Corporate Social Responsibility
Healthcare and sharing knowledge are in the heart of our CSR activities
Events
Our highlighted past and future events you shouldn't miss

Cookie Settings

Egis’s website uses cookies to run our website, improve the user experience and monitor the activities. You can customize the use of the cookies by adapting the settings.

Cookies necessary for basic functioning

These cookies ensure the appropriate functioning of the website, facilitate its use and collect information on its use without identifying visitors.

Functional cookies

In order to enhance the user experience, we use cookies which record the use of certain functions of the website, thus enabling users to have the same settings at the time of their next visit.

Cookies for statistical purposes

They provide statistical data on the performance of the website (such as number of page loads, average time spent on the website) in order to collect data for the operator of the website on the website usage patterns of users. These cookies do not identify visitors, information collected by them relate to the number of subpages visited by the user, the length of each session, the types of error messages, etc. Cookies for statistical purposes are automatically placed on the user’s devices during browsing, and you can delete such cookies in the browser settings.
Details
I Agree
WarningYour browser is out of date. Please, use an updated version! Chrome || Firefox